Akebia Therapeutics, Inc.
USD1.14
+0.03 (+2.25%)
CEO
John Butler
IPO Date
2014-03-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.28
Prev. Close
$1.11
Day Low
$1.11
Day High
$1.29
52W Low
$0.82
52W High
$4.08
Market Cap
$0.30B
Volume
4.67M
| -5.8 |
| 31 Dec 2023 | FY | 61.9% | -26.7% | 169.8% | -21.5% | -3.41 | 1.18 | -4.5 |
| 31 Dec 2022 | FY | 92.3% | -32.2% | -1801.6% | -26.5% | 19.08 | 1.43 | -1.1 |
| 31 Dec 2021 | FY | 61.5% | -133.3% | -381.1% | -53.3% | 1.84 | 1.04 | -1.3 |
| 31 Dec 2020 | FY | 78.3% | -130.6% | -155.4% | -59.7% | 0.51 | 1.98 | -1.0 |
| 31 Dec 2019 | FY | 56.6% | -83.5% | -70.8% | -36.3% | 0.27 | 1.49 | -2.7 |
| 31 Dec 2018 | FY | 96.3% | -82.7% | -27.0% | -17.3% | 0.02 | 1.76 | -3.8 |
| 31 Dec 2017 | FY | 99.7% | -43.2% | -64.5% | -21.1% | 0.00 | 2.48 | -8.4 |
| 31 Dec 2016 | FY | -7443.0% | -8843.5% | -199.3% | -45.2% | 0.00 | 2.59 | -2.9 |
| -8.7 |
| 30 Sept 2025 | Q3 | 83.5% | 0.9% | 1.3% | 0.1% | 1.26 | 1.94 | 334.7 |
| 30 Jun 2025 | Q2 | 84.1% | 0.4% | 0.8% | 0.1% | 1.83 | 1.98 | 967.3 |
| 31 Mar 2025 | Q1 | 86.7% | 10.7% | 24.9% | 2.0% | 2.20 | 2.23 | 18.5 |
| 31 Dec 2024 | Q4 | 56.2% | -49.0% | 46.4% | -10.3% | -3.84 | 1.41 | -4.6 |
| 30 Sept 2024 | Q3 | 62.2% | -53.5% | 39.8% | -9.7% | -1.01 | 1.52 | -3.5 |
| 30 Jun 2024 | Q2 | 81.0% | -19.7% | 25.4% | -3.9% | -3.10 | 1.04 | -6.1 |
| 31 Mar 2024 | Q1 | 91.7% | -55.2% | 66.0% | -8.0% | -1.57 | 1.70 | -4.6 |
| 31 Dec 2023 | Q4 | 66.8% | 1.1% | -2.0% | 0.3% | -1.57 | 1.18 | 95.9 |